We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines.
#SheInspires, The inspiring tales of our own Women In Science at Biocon Biologics.
Kiran Mazumdar-Shaw speaking on Biocon’s Q1 FY23 Earnings
Insulin Glargine: Journey to the historic U.S. approval for the first interchangeable biosimilar
Biocon Biologics Global Scale Capabilities